Clinicopathological factors associated with the presence of tumor deposits in resected gastric cancer patients

Descripción del Articulo

Purpose: The role of tumor deposits (TDs) in the staging of gastric cancer is currently debatable. TDs are defined as tumoral nodules in perigastric adipose tissue with no evidence of lymphatic, vascular, or neural structures. Clinicopathological factors related to the presence of TDs are not well d...

Descripción completa

Detalles Bibliográficos
Autores: Paredes Torres, O, Prado Cucho, S, Taxa Rojas, L, Luque-Vasquez, C, Chavez, I, Payet Meza, E, Ruiz Figueroa, E, Berrospi Espinoza, F
Formato: artículo
Fecha de Publicación:2021
Institución:Instituto Nacional de Enfermedades Neoplásicas
Repositorio:INEN-Institucional
Lenguaje:inglés
OAI Identifier:oai:repositorio.inen.sld.pe:inen/57
Enlace del recurso:https://repositorio.inen.sld.pe/handle/inen/57
Nivel de acceso:acceso abierto
Materia:Dspace
Open access
Repositorio digital
https://purl.org/pe-repo/ocde/ford#3.02.21
id INEN_9791efe0507891fa5b595e79fab86031
oai_identifier_str oai:repositorio.inen.sld.pe:inen/57
network_acronym_str INEN
network_name_str INEN-Institucional
repository_id_str .
spelling Paredes Torres, OPrado Cucho, STaxa Rojas, LLuque-Vasquez, CChavez, IPayet Meza, ERuiz Figueroa, EBerrospi Espinoza, F2024-04-05T13:57:03Z2024-04-05T13:57:03Z2021Purpose: The role of tumor deposits (TDs) in the staging of gastric cancer is currently debatable. TDs are defined as tumoral nodules in perigastric adipose tissue with no evidence of lymphatic, vascular, or neural structures. Clinicopathological factors related to the presence of TDs are not well defined. This study aimed to identify the clinicopathological factors associated with the presence of TDs in resected gastric cancer patients. Materials and methods: This prospective study included patients diagnosed with gastric cancer and treated with D2 radical gastrectomy from January 2019 to January 2020. Univariate and multivariate analyses were performed to determine the factors related to the presence of TDs. Results: A total of 111 patients were eligible and TDs were present in 31 of them (28%). In the univariate analysis, male gender (p = 0.027), tumor size ≥ 5cm (p = ≤0.001), serosa and adjacent organs invasion (pT4a and pT4b) (p = ≤0.001), ≥16 metastatic lymph nodes (pN3b) (p = ≤0.001), and TNM stage III tumors (p = ≤0.001) were significantly associated with the presence of TDs. The multivariate analysis showed that a tumors size ≥5 cm (OR = 3.69, 95% CI: 1.17-11.6), serosa and adjacent organs invasion (pT4a and pT4b) (OR = 3.78, 95% CI: 1.31-10.86) and ≥16 metastatic lymph nodes (pN3b) (OR = 3.21, 95%CI:1.06-9.7) were independent risk factors for the presence of TDs. Conclusions: Larger tumors (tumor size ≥ 5cm), serosa and adjacent organs invasion (pT4 and pT4b), and ≥16 metastatic lymph nodes (pN3b) were independent risk factors for the presence of TDs. Keywords: Gastric cancer; Pathology; Surgery; Tumor deposits (TDs).application/pdf10.1016/j.heliyon.2021.e07185https://repositorio.inen.sld.pe/handle/inen/57engHeliyonNLElsevier BVinfo:eu-repo/semantics/openAccessdc.rights.uri: https//creativecomons.org/licenses/by/4.0/DspaceOpen accessRepositorio digitalhttps://purl.org/pe-repo/ocde/ford#3.02.21Clinicopathological factors associated with the presence of tumor deposits in resected gastric cancer patientsinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionreponame:INEN-Institucionalinstname:Instituto Nacional de Enfermedades Neoplásicasinstacron:INENPublicationORIGINALOP Torres 2021.pdfapplication/pdf697706https://repositorio.inen.sld.pe/bitstreams/fb687e16-9bcb-4db9-a029-044d7ebcb727/downloadd7755e65f20336e1b2ed4a2f95686e3cMD51TEXTOP Torres 2021.pdf.txtOP Torres 2021.pdf.txtExtracted texttext/plain34587https://repositorio.inen.sld.pe/bitstreams/a8deee5c-7c78-4345-953c-a27ca008a13a/download7ac0c2a0b5523ab338aa87d97651bdd3MD52THUMBNAILOP Torres 2021.pdf.jpgOP Torres 2021.pdf.jpgGenerated Thumbnailimage/jpeg5537https://repositorio.inen.sld.pe/bitstreams/b714a9de-befb-4e70-a978-9d02d9ae924a/download4ccb46cac70b3397a1e587f67ab06f73MD53inen/57oai:repositorio.inen.sld.pe:inen/572024-10-24 03:00:23.713dc.rights.uri: https//creativecomons.org/licenses/by/4.0/info:eu-repo/semantics/openAccesshttps://repositorio.inen.sld.peRepositorio INENrepositorioinendspace@gmail.com
dc.title.none.fl_str_mv Clinicopathological factors associated with the presence of tumor deposits in resected gastric cancer patients
title Clinicopathological factors associated with the presence of tumor deposits in resected gastric cancer patients
spellingShingle Clinicopathological factors associated with the presence of tumor deposits in resected gastric cancer patients
Paredes Torres, O
Dspace
Open access
Repositorio digital
https://purl.org/pe-repo/ocde/ford#3.02.21
title_short Clinicopathological factors associated with the presence of tumor deposits in resected gastric cancer patients
title_full Clinicopathological factors associated with the presence of tumor deposits in resected gastric cancer patients
title_fullStr Clinicopathological factors associated with the presence of tumor deposits in resected gastric cancer patients
title_full_unstemmed Clinicopathological factors associated with the presence of tumor deposits in resected gastric cancer patients
title_sort Clinicopathological factors associated with the presence of tumor deposits in resected gastric cancer patients
author Paredes Torres, O
author_facet Paredes Torres, O
Prado Cucho, S
Taxa Rojas, L
Luque-Vasquez, C
Chavez, I
Payet Meza, E
Ruiz Figueroa, E
Berrospi Espinoza, F
author_role author
author2 Prado Cucho, S
Taxa Rojas, L
Luque-Vasquez, C
Chavez, I
Payet Meza, E
Ruiz Figueroa, E
Berrospi Espinoza, F
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Paredes Torres, O
Prado Cucho, S
Taxa Rojas, L
Luque-Vasquez, C
Chavez, I
Payet Meza, E
Ruiz Figueroa, E
Berrospi Espinoza, F
dc.subject.none.fl_str_mv Dspace
Open access
Repositorio digital
topic Dspace
Open access
Repositorio digital
https://purl.org/pe-repo/ocde/ford#3.02.21
dc.subject.ocde.none.fl_str_mv https://purl.org/pe-repo/ocde/ford#3.02.21
description Purpose: The role of tumor deposits (TDs) in the staging of gastric cancer is currently debatable. TDs are defined as tumoral nodules in perigastric adipose tissue with no evidence of lymphatic, vascular, or neural structures. Clinicopathological factors related to the presence of TDs are not well defined. This study aimed to identify the clinicopathological factors associated with the presence of TDs in resected gastric cancer patients. Materials and methods: This prospective study included patients diagnosed with gastric cancer and treated with D2 radical gastrectomy from January 2019 to January 2020. Univariate and multivariate analyses were performed to determine the factors related to the presence of TDs. Results: A total of 111 patients were eligible and TDs were present in 31 of them (28%). In the univariate analysis, male gender (p = 0.027), tumor size ≥ 5cm (p = ≤0.001), serosa and adjacent organs invasion (pT4a and pT4b) (p = ≤0.001), ≥16 metastatic lymph nodes (pN3b) (p = ≤0.001), and TNM stage III tumors (p = ≤0.001) were significantly associated with the presence of TDs. The multivariate analysis showed that a tumors size ≥5 cm (OR = 3.69, 95% CI: 1.17-11.6), serosa and adjacent organs invasion (pT4a and pT4b) (OR = 3.78, 95% CI: 1.31-10.86) and ≥16 metastatic lymph nodes (pN3b) (OR = 3.21, 95%CI:1.06-9.7) were independent risk factors for the presence of TDs. Conclusions: Larger tumors (tumor size ≥ 5cm), serosa and adjacent organs invasion (pT4 and pT4b), and ≥16 metastatic lymph nodes (pN3b) were independent risk factors for the presence of TDs. Keywords: Gastric cancer; Pathology; Surgery; Tumor deposits (TDs).
publishDate 2021
dc.date.accessioned.none.fl_str_mv 2024-04-05T13:57:03Z
dc.date.available.none.fl_str_mv 2024-04-05T13:57:03Z
dc.date.issued.fl_str_mv 2021
dc.type.none.fl_str_mv info:eu-repo/semantics/article
dc.type.version.none.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.doi.none.fl_str_mv 10.1016/j.heliyon.2021.e07185
dc.identifier.uri.none.fl_str_mv https://repositorio.inen.sld.pe/handle/inen/57
identifier_str_mv 10.1016/j.heliyon.2021.e07185
url https://repositorio.inen.sld.pe/handle/inen/57
dc.language.iso.none.fl_str_mv eng
language eng
dc.relation.ispartof.none.fl_str_mv Elsevier BV
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.none.fl_str_mv dc.rights.uri: https//creativecomons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv dc.rights.uri: https//creativecomons.org/licenses/by/4.0/
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Heliyon
dc.publisher.country.none.fl_str_mv NL
publisher.none.fl_str_mv Heliyon
dc.source.none.fl_str_mv reponame:INEN-Institucional
instname:Instituto Nacional de Enfermedades Neoplásicas
instacron:INEN
instname_str Instituto Nacional de Enfermedades Neoplásicas
instacron_str INEN
institution INEN
reponame_str INEN-Institucional
collection INEN-Institucional
bitstream.url.fl_str_mv https://repositorio.inen.sld.pe/bitstreams/fb687e16-9bcb-4db9-a029-044d7ebcb727/download
https://repositorio.inen.sld.pe/bitstreams/a8deee5c-7c78-4345-953c-a27ca008a13a/download
https://repositorio.inen.sld.pe/bitstreams/b714a9de-befb-4e70-a978-9d02d9ae924a/download
bitstream.checksum.fl_str_mv d7755e65f20336e1b2ed4a2f95686e3c
7ac0c2a0b5523ab338aa87d97651bdd3
4ccb46cac70b3397a1e587f67ab06f73
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositorio INEN
repository.mail.fl_str_mv repositorioinendspace@gmail.com
_version_ 1847510642857082880
score 12.832809
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).